Showing results (1-10 of 58) with videos related to
Sort By:
Pageof 6
Tropical Medicine & International Health : TM & IH|April 14, 2004
Importance of nosocomial respiratory syncytial virus infections in an African settingShabir A Madhi, Kuraysha Ismail, Cathryn O'Reilly, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 22, 2005
The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected childrenShabir A Madhi, Locadiah Kuwanda, Clare Cutland, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 9, 2006
Five-year cohort study of hospitalization for respiratory syncytial virus associated lower respiratory tract infection in African childrenShabir A Madhi, Locadiah Kuwanda, Clare Cutland, et al.South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|June 18, 2011
Immunogenicity and safety of an acellular pertussis, diphtheria, tetanus, inactivated poliovirus, Hib-conjugate combined vaccine (Pentaxim) and monovalent hepatitis B vaccine at 6, 10 and 14 weeks of age in infants in South AfricaShabir Ahmed Madhi, Clare Cutland, Stephanie Jones, et al.Heliyon|February 8, 2021
Knowledge and attitudes towards maternal immunization: perspectives from pregnant and non-pregnant mothers, their partners, mothers, healthcare providers, community and leaders in a selected urban setting in South AfricaMotlatso Godongwana, Nellie Myburgh, Sunday A Adedini, et al.South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|January 26, 2012
One-year post-primary antibody persistence and booster immune response to a DTaP-IPV//PRP~T vaccine (Pentaxim) given at 18 - 19 months of age in South African children primed at 6, 10 and 14 weeks of age with the same vaccineShabir Ahmed Madhi, Clare Cutland, Stephanie Jones, et al.Journal of Urban Health : Bulletin of the New York Academy of Medicine|April 5, 2024
Assessing New York City's COVID-19 Vaccine Rollout Strategy: A Case for Risk-Informed DistributionNina Schwalbe, Marta C Nunes, Clare Cutland, et al.The Pediatric Infectious Disease Journal|February 4, 2011
Immunogenicity and safety of an investigational fully liquid hexavalent combination vaccine versus licensed combination vaccines at 6, 10, and 14 weeks of age in healthy South African infantsShabir A Madhi, Ismail Mitha, Clare Cutland, et al.The Pediatric Infectious Disease Journal|January 6, 2006
Usefulness of C-reactive protein to define pneumococcal conjugate vaccine efficacy in the prevention of pneumoniaShabir A Madhi, Mariane Kohler, Locadiah Kuwanda, et al.The Pediatric Infectious Disease Journal|March 30, 2013
Antibody persistence and booster vaccination of a fully liquid hexavalent vaccine coadministered with measles/mumps/rubella and varicella vaccines at 15-18 months of age in healthy South African infantsShabir A Madhi, Anthonet Koen, Clare Cutland, et al.Pageof 6